- Home
- JKS vs RLAY Comparison
JKS vs RLAY Comparison
Compare JKS & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JKS | RLAY |
|---|---|---|
| Founded | 2006 | 2015 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2010 | 2020 |
Fundamental Metrics
Financial Performance| Metric | JKS | RLAY |
|---|---|---|
| Price | $27.44 | $8.56 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $19.49 | $16.00 |
| AVG Volume (30 Days) | 490.9K | ★ 2.2M |
| Earning Date | 11-17-2025 | 11-06-2025 |
| Dividend Yield | ★ 4.77% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,641,756,390.00 | $8,355,000.00 |
| Revenue This Year | N/A | $20.47 |
| Revenue Next Year | $30.78 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.42 | $1.78 |
| 52 Week High | $31.88 | $9.04 |
Technical Indicators
Market Signals| Indicator | JKS | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 56.27 | 63.56 |
| Support Level | $26.63 | $8.13 |
| Resistance Level | $28.70 | $8.76 |
| Average True Range (ATR) | 1.23 | 0.49 |
| MACD | 0.14 | 0.01 |
| Stochastic Oscillator | 74.61 | 73.77 |
Price Performance
Historical ComparisonAbout JKS JinkoSolar Holding Company Limited (each representing 4)
JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific, and the Rest of the world.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).